Skip to content

Artichoke extract

Also called artichoke leaf extract, globe artichoke, Cynara cardunculus (syn. Cynara scolymus). Botanical extract (leaf); contains caffeic acid derivatives and the flavonoids luteolin and apigenin.

Evidence last reviewed Added to the site 26 studies citedEditorial review: NootropicsWork Editorial TeamEducational, not medical advice

Bottom line

Artichoke leaf extract, from globe artichoke leaves, contains the flavonoid luteolin [16][32]. Meta-analyses found modest falls in triglycerides and mixed blood pressure results [1][3][6][7]. Memory and focus claims rest on cell and animal work, and one small alcohol-challenge trial (product donated by Boots) found no significant cognitive change [10][11][14]. Regulators advise against use with a bile duct obstruction [29][31].

  • In a meta-analysis of 9 trials with 702 participants, artichoke extract was associated with triglycerides 9.2 mg/dL lower on average than control [1].
  • Blood pressure findings are mixed: one meta-analysis found small falls, while another found no overall effect and a fall only in people with hypertension [6][7].
  • Luteolin, a flavonoid in artichoke leaves, inhibited the enzyme PDE4 in laboratory studies, which is mechanism, not evidence of an effect in people [14][16].
  • In the one placebo-controlled trial with cognitive tests we found, 15 healthy adults tested 10 hours after an alcohol challenge showed no significant difference from placebo after artichoke extract; the study product was donated by Boots the Chemist [10].
  • Health Canada says not to use artichoke products with a bile duct obstruction, and the EU monograph also lists Asteraceae allergy, gallstones and liver disease [29][31].

Evidence by outcome

OutcomeGradeBasisModifiersRationale
Acute cognitive performanceC Limited, no effect foundOne small randomized, double-blind crossover trial in healthy adults, null on cognitive testsShort-term onlyWhy C grade for Acute cognitive performance: explainedApproved of the Acute cognitive performance grade
Blood pressureC Limited, no effect foundMeta-analyses disagree, and the positive subgroup is a clinical population; conservative reading of mixed evidenceWhy C grade for Blood pressure: explainedApproved of the Blood pressure grade
Blood triglyceridesC LimitedMeta-analyses whose abstracts do not separate healthy from clinical populations, with the individually read trials in people with raised lipids; the one trial in otherwise healthy adults found no triglyceride differenceWhy C grade for Blood triglycerides: explainedApproved of the Blood triglycerides grade
MemoryD PreliminaryAnimal and cell evidence only; no controlled human outcome dataWhy D grade for Memory: explainedApproved of the Memory grade

Grades describe evidence for each outcome, not a recommendation. Open a grade for its rationale and dated grade history. How we grade

Most human trials of artichoke extract measured blood lipids, blood pressure or digestion, often in people with raised cholesterol, hypertension or functional dyspepsia, and each section names the population. Results in clinical groups may not apply to healthy adults. The evidence grading method explains what each grade requires.

Does artichoke extract lower blood triglycerides?

Two meta-analyses found reductions, but the abstracts do not say how many participants were healthy [1][3]. A meta-analysis is a study that pools the results of earlier trials. In a 2018 meta-analysis of 9 randomized trials with 702 participants, artichoke extract was associated with lower triglycerides, by a weighted mean difference of 9.2 mg/dL (95% CI -16.2 to -2.1) compared with control [1]. The same analysis found lower total cholesterol (-17.6 mg/dL) and LDL cholesterol (-14.9 mg/dL), no significant change in HDL cholesterol, and a larger LDL effect in people with higher starting LDL [1]. A 2025 synthesis of controlled trials, searched to September 2024, also found lower triglycerides (WMD -12.85 mg/dL) and concluded that artichoke may offer modest improvements [3].

A third meta-analysis, which rated certainty with the GRADE approach, pooled 15 effect sizes from 14 studies [2]. It found lower LDL cholesterol (WMD -17.48 mg/dl) and no effect on HDL cholesterol [2]. Its abstract prints the same figures for triglycerides as for total cholesterol, with different p values, so we do not report its triglyceride estimate.

The trial closest to healthy adults did not find a triglyceride effect [4]. In 75 otherwise healthy adults with mild to moderate hypercholesterolemia, 1280 mg of a standardized extract daily for 12 weeks lowered total cholesterol by 4.2% while it rose 1.9% on placebo, but triglyceride, LDL and HDL levels did not differ between groups [4]. General well-being improved in both groups, with no difference between them [4]. In a 6-week trial of 143 adults with hyperlipoproteinemia, a clinical population, 1,800 mg a day of the branded CY450 extract lowered total cholesterol by 18.5% against 8.6% on placebo [5]. Triglycerides were not reported in that abstract.

Does artichoke extract affect blood pressure?

Evidence is mixed: one meta-analysis found small falls, and another found no overall effect [6][7]. A 2022 meta-analysis of 7 trials with 472 participants found lower systolic pressure (WMD -2.01 mmHg; 95% CI -3.78 to -0.24) and diastolic pressure (WMD -1.45 mmHg) with artichoke [6]. Its authors reported larger falls in systolic pressure in trials using 500 mg or less, lasting more than 8 weeks, with participants under 50, and with 70 or fewer participants, and non-linear links with dose and duration [6]. A 2025 synthesis found similar falls of 2.49 mmHg systolic and 1.53 mmHg diastolic [3].

A 2021 meta-analysis of 8 randomized trials found no overall effect on systolic (WMD -0.77 mmHg; 95% CI -2.76 to 1.22) or diastolic pressure compared with placebo [7]. A subgroup analysis suggested that systolic pressure may fall in people with hypertension (by 3.19 mmHg), with no reduction in people with fatty liver disease [7]. Results in clinical groups may not apply to healthy adults.

The individual trials we read enrolled people with hypertension [8][9]. In an 8-week trial of 40 patients with hypertension who were also taking a blood pressure medicine, 500 mg of artichoke twice daily improved body mass index compared with placebo, and the authors said more trials are needed to confirm or reject an effect on blood pressure [8]. In a 12-week trial in people with mild hypertension, diastolic pressure fell compared with placebo after 50 or 100 mg of artichoke juice concentrate [9].

Does artichoke extract affect thinking in short-term use?

Not in the one placebo-controlled trial we found [10]. In a randomized, double-blind crossover trial, 15 healthy adults aged 18 to 65 took 3 capsules of 320 mg standardized artichoke extract (LI120), or placebo, immediately before and after drinking alcohol [10]. A crossover trial gives each person both treatments in turn. Cognitive tests (a switching test, a 4-choice reaction test and an odd-man-out letter test) were run 1 hour before and 10 hours after drinking [10]. None of the outcomes, including hangover severity, mood and test results, differed significantly between artichoke and placebo [10]. The capsules and placebos were donated by Boots the Chemist, and the authors declared no competing interests [10].

The trial was small, and the tests were secondary outcomes in a hangover study, so it shows limited evidence of no effect rather than proof of none [10].

Does artichoke extract or luteolin improve memory?

The evidence is from animals only [11][12][13]. In aged mice, luteolin added to the diet for 4 weeks improved spatial working memory, and it did not change memory in young adult mice [11]. In mice fed a high-fat diet, oral luteolin at 10 mg/kg improved performance in a water maze and a step-through avoidance task [12]. In rats with experimental bile duct ligation, artichoke leaf and receptaculum extracts given for 28 days improved object recognition [13]. The mouse studies used pure luteolin, not artichoke extract [11][12].

As of November 11, 2026 we found no randomized trials of artichoke extract or luteolin on memory or attention in healthy adults (PubMed and Europe PMC search, November 11, 2026).

What the evidence does not show

The studies above do not show that artichoke extract improves focus, memory or energy in healthy people. Human luteolin trials we found tested it in clinical groups or in combinations [22][23]. In a placebo-controlled crossover screening trial in 21 male veterans with Gulf War Illness, a clinical population, luteolin did not reduce symptom severity more than placebo at either dose [22]. In 12 physically active men, a combination of luteolin and mangiferin improved sprint performance, in a study partly financed by Nektium Pharma, which supplied the compounds; luteolin was not tested alone [23].

Other trials looked at different questions. In competitive rowers, 400 mg of artichoke leaf extract three times a day for 5 weeks raised plasma antioxidant capacity but did not limit oxidative damage to red blood cells [21]. In 247 people with functional dyspepsia, a clinical population, a commercial extract improved digestive symptoms more than placebo over 6 weeks [19]. A meta-analysis of 8 trials found lower liver enzymes (AST and ALT) with artichoke than with placebo, mainly in people with fatty liver disease, a clinical population [20], and a 2025 synthesis also found lower ALT [3].

Doses used in studies

Ranges researchers used, not dosing advice. Bars share one scale. Read our disclaimer.

Otherwise healthy adults with raised cholesterol, 12 weeks1280 mg standardized extract daily1280 mg
Adults with hyperlipoproteinemia (clinical population), 6 weeks1,800 mg dry extract daily (branded CY450)1.8 mg
People with hypertension (clinical population), 8-12 weeks500 mg twice daily; 50 or 100 mg juice concentrate500 mg
People with functional dyspepsia (clinical population), 6 weeks2 x 320 mg three times daily320 mg
Healthy adults, alcohol challenge, one day1.92 g (3 x 320 mg before and after alcohol)

1.92 g (3 x 320 mg before and after alcohol)

Competitive rowers, 5 weeks400 mg three times daily400 mg

Timing and form

The forms studied include tablets and capsules of dry extract, juice concentrate, and leaf powder [5][8][9]. The EU monograph also covers herbal tea from dried leaves [31].

How the body handles artichoke compounds has been studied in one small human study [18]. Ten healthy volunteers took three capsules of artichoke extract 4 hours apart; the original polyphenols were not detected in urine, but the caffeic acid derivatives were absorbed and excreted as methylated phenolic acids such as ferulic and vanillic acid [18]. A review of luteolin covers its absorption, metabolism and bioavailability from food [17]. As of November 11, 2026 we found no human study measuring blood levels of luteolin after artichoke extract (PubMed search, November 11, 2026).

The EU monograph says a doctor or qualified health care practitioner should be consulted if digestive symptoms persist longer than 2 weeks during use [31]. Health Canada's monograph requires no statement on duration of use [29].

What it is

Artichoke extract is made from the leaves of the globe artichoke, Cynara cardunculus, a plant also known by the older name Cynara scolymus [32]. Health Canada lists artichoke thistle, cardoon, common artichoke and globe artichoke among its common names, with dry or fresh leaf as the source material [29]. The plant is grown as a food, mainly in the Mediterranean, and its leaves are used mostly in infusions and extracts [16]. It is sold in plant-based dietary supplements and herbal infusions [16].

The European Medicines Agency's herbal monograph covers dried leaves for tea, powdered leaves, and dry or soft extracts made with water or dilute ethanol [31]. The main phenolic compounds in artichoke heads and leaves are caffeic acid derivatives, and the flavonoids luteolin and apigenin are also present, as glucosides and rutinosides [16]. Luteolin is a flavone, a subclass of flavonoids, and is common in food plants [17]. One capsule used in a human metabolism study held 320 mg of extract with 34.3 mg/g caffeic acid derivatives and 5.6 mg/g flavonoids [18].

How it works (mechanism, not effect): luteolin inhibits phosphodiesterases, enzymes that break down the cell-signaling molecule cAMP [15]. In enzyme assays, luteolin competitively inhibited phosphodiesterases 1 to 5 [14]. Only its PDE4 inhibition explained a reversal of anesthesia in mice, and luteolin needed 11.2 microM to displace a PDE4 marker, compared with 45.6 nM for a selective research PDE4 inhibitor [14]. Luteolin also inhibited PDE4 activity in rat endothelial cells [15]. These are laboratory and animal findings. They do not show that artichoke extract changes memory or focus in people.

Safety and interactions

Safety flag. Health Canada's monograph says not to use artichoke products with a bile duct obstruction and to ask a practitioner first if pregnant or with gallstones [29]. The EU monograph contraindicates artichoke leaf with allergy to the Asteraceae family, bile duct obstruction, cholangitis, liver disease or gallstones [31]. Reported side effects include slight diarrhea with abdominal spasm, nausea, heartburn and allergic reactions, at unknown frequency [31]. In a rat study, high doses during pregnancy reduced fetal weight and length; this is animal data [26].

Who sources say should be careful.

  • People with a bile duct obstruction, gallstones or liver disease. Health Canada contraindicates bile duct obstruction and asks people with gallstones to consult a practitioner first [29]; the EU monograph contraindicates bile duct obstruction, cholangitis, liver disease and gallstones [31].
  • People allergic to plants in the Asteraceae (daisy) family. The EU monograph lists this as a contraindication [31].
  • Pregnant or breastfeeding women. The EU monograph says safety has not been established and use is not recommended, and Health Canada asks pregnant women to consult a practitioner first [31][29]. In a rat study, high doses of extract during pregnancy reduced fetal weight and length and, at the highest dose, the number of live pups, without malformations [26]. As of November 11, 2026 we found no human safety studies in pregnancy, breastfeeding or children (PubMed search, November 11, 2026).
  • Children under 12. The EU monograph says use in this age group has not been established for lack of adequate data [31].

The EU monograph lists slight diarrhea with abdominal spasm, nausea and heartburn, and says allergic reactions may occur, all at unknown frequency [31]. It reports no case of overdose, and notes that adequate tests of reproductive toxicity, genotoxicity and carcinogenicity have not been performed [31]. Health Canada requires products to tell people to stop use if hypersensitivity or allergy occurs [29].

Trials reported few problems [5][10]. In the hangover trial, whose study product was donated by Boots the Chemist, adverse events were rare, mild and transient [10]. The 143-person trial of the CY450 extract reported no drug-related adverse events [5].

A laboratory paper on luteolin's PDE4 action noted that nausea, vomiting and gastric hypersecretion should be monitored when luteolin is used, a caution drawn from its enzyme profile, not from a human trial [14].

Our safety flag rests on regulator contraindications. Health Canada says not to use artichoke products if you have a bile duct obstruction [29], and the EU monograph contraindicates artichoke leaf in bile duct obstruction, cholangitis, liver disease, gallstones and allergy to plants of the Asteraceae family [31].

Interactions sources report

The EU herbal monograph lists no reported interactions with other medicines [31]. As of November 11, 2026 we found no human study of artichoke extract combined with any medicine (PubMed and Europe PMC search, November 11, 2026).

Laboratory and animal studies raise questions that have not been tested in people [24][25]. In an in vitro study of nine standardized plant extracts, including artichoke, the extracts flagged for inhibiting the drug-metabolizing enzymes CYP3A4 and CYP2D6 were red embauba and yerba mate [24]. In rats, a concentrated luteolin formulation increased blood levels of atorvastatin, a cholesterol-lowering statin, by inhibiting drug-handling enzymes and transporters [25]. That study did not use artichoke extract.

Some trials gave artichoke alongside medicines. The authors of the 2018 lipid meta-analysis suggested artichoke might increase the effect of lipid-lowering therapy in people with hyperlipidemia, which was not tested [1]. One blood pressure trial gave artichoke to people already taking captopril, and its abstract reports no interaction outcomes [8].

These sources describe what has been reported, not what is right for any individual. If you take any of these medicines, talk to your doctor or pharmacist before combining them with artichoke extract.

FAQ

Does artichoke extract help focus or memory?

In a small crossover trial in 15 healthy adults tested 10 hours after an alcohol challenge, cognitive test results did not differ significantly between artichoke extract and placebo; the study product was donated by Boots the Chemist [10]. Memory findings come from animals: luteolin in mice [11][12] and artichoke extract in rats with experimental bile duct ligation [13], and as of November 11, 2026 we found no randomized trials of artichoke extract or luteolin on memory or attention in healthy adults (PubMed and Europe PMC search, 2026-11-11).

What is the link between artichoke, luteolin and PDE4?

Artichoke leaves contain luteolin [16], and in laboratory studies luteolin inhibited phosphodiesterase enzymes, including PDE4 [14][15]. This is mechanism; it has not been shown to change thinking in people.

What are the side effects of artichoke extract?

The EU herbal monograph lists slight diarrhea with abdominal spasm, nausea, heartburn and allergic reactions, with frequency not known [31]. In a hangover trial with study product donated by Boots the Chemist, adverse events were rare, mild and transient [10].

How much artichoke extract did studies use?

Lipid trials used 1280 mg daily for 12 weeks [4] and 1,800 mg daily for 6 weeks [5], and a blood pressure trial used 500 mg twice daily for 8 weeks [8]. These are study doses, not advice.

References

  1. Sahebkar A, Pirro M, Banach M, et al. Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2018.PMID 28609140DOI 10.1080/10408398.2017.1332572Tier 1, meta-analysis
  2. Shahinfar H, Bazshahi E, Amini MR, et al. Effects of artichoke leaf extract supplementation or artichoke juice consumption on lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res. 2021.PMID 34569671DOI 10.1002/ptr.7247Tier 1, systematic review
  3. Jafari A, Karimi MA, Mahmoudinezhad M, et al. Artichoke and cardiometabolic health: A systematic and meta-analytic synthesis of current evidence. Diabetes Metab Syndr. 2025.PMID 41270328DOI 10.1016/j.dsx.2025.103328Tier 1, meta-analysis
  4. Bundy R, Walker AF, Middleton RW, et al. Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial. Phytomedicine. 2008.PMID 18424099DOI 10.1016/j.phymed.2008.03.001Tier 1, RCT
  5. Englisch W, Beckers C, Unkauf M, et al. Efficacy of Artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung. 2000.PMID 10758778DOI 10.1055/s-0031-1300196Tier 1, RCT
  6. Amini MR, Sheikhhossein F, Alvani M, et al. Anti-hypertensive Effects of Artichoke Supplementation in Adults: A Systematic Review and Dose-response Meta-analysis of Randomized Controlled Trials. Clin Nutr Res. 2022.PMID 35949557DOI 10.7762/cnr.2022.11.3.214Tier 1
  7. Moradi M, Sohrabi G, Golbidi M, et al. Effects of artichoke on blood pressure: A systematic review and meta-analysis. Complement Ther Med. 2021.PMID 33465383DOI 10.1016/j.ctim.2021.102668Tier 1, meta-analysis
  8. Ardalani H, Jandaghi P, Meraji A, et al. The Effect of Cynara scolymus on Blood Pressure and BMI in Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Complement Med Res. 2020.PMID 31484191DOI 10.1159/000502280Tier 1, RCT
  9. Roghani-Dehkordi F, Kamkhah AF. Artichoke leaf juice contains antihypertensive effect in patients with mild hypertension. J Diet Suppl. 2009.PMID 22435514DOI 10.3109/19390210903280207Tier 1, RCT
  10. Pittler MH, White AR, Stevinson C, et al. Effectiveness of artichoke extract in preventing alcohol-induced hangovers: a randomized controlled trial. CMAJ. 2003.PMID 14662662Tier 1, RCT
  11. Jang S, Dilger RN, Johnson RW. Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. J Nutr. 2010.PMID 20685893DOI 10.3945/jn.110.123273Tier 1
  12. Liu Y, Fu X, Lan N, et al. Luteolin protects against high fat diet-induced cognitive deficits in obesity mice. Behav Brain Res. 2014.PMID 24667364DOI 10.1016/j.bbr.2014.02.040Tier 1
  13. Kam Ö, Bebitoğlu BT, Şener G, et al. Protective effect of artichoke (Cynara scolymus L.) leaf and receptaculum extracts against hepatic encephalopathy in bile duct ligated rats. Metab Brain Dis. 2025.PMID 41055772DOI 10.1007/s11011-025-01701-yTier 1
  14. Yu MC, Chen JH, Lai CY, et al. Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1-5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia. Eur J Pharmacol. 2010.PMID 19853596DOI 10.1016/j.ejphar.2009.10.031Tier 1
  15. Kong X, Huo G, Liu S, et al. Luteolin suppresses inflammation through inhibiting cAMP-phosphodiesterases activity and expression of adhesion molecules in microvascular endothelial cells. Inflammopharmacology. 2019.PMID 30276558DOI 10.1007/s10787-018-0537-2Tier 1
  16. Olas B. An Overview of the Versatility of the Parts of the Globe Artichoke (Cynara scolymus L.), Its By-Products and Dietary Supplements. Nutrients. 2024.PMID 38474726DOI 10.3390/nu16050599Tier 1, narrative review
  17. Wang Z, Zeng M, Wang Z, et al. Dietary Luteolin: A Narrative Review Focusing on Its Pharmacokinetic Properties and Effects on Glycolipid Metabolism. J Agric Food Chem. 2021.PMID 33522240DOI 10.1021/acs.jafc.0c08085Tier 1, narrative review
  18. Rechner AR, Pannala AS, Rice-Evans CA. Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo. Free Radic Res. 2001.PMID 11697200DOI 10.1080/10715760100300741Tier 1, controlled trial
  19. Holtmann G, Adam B, Haag S, et al. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther. 2003.PMID 14653829DOI 10.1046/j.1365-2036.2003.01767.xTier 1, RCT
  20. Moradi S, Shokri-Mashhadi N, Saraf-Bank S, et al. The effects of Cynara scolymus L. supplementation on liver enzymes: A systematic review and meta-analysis. Int J Clin Pract. 2021.PMID 34383355DOI 10.1111/ijcp.14726Tier 1, meta-analysis
  21. Skarpanska-Stejnborn A, Pilaczynska-Szczesniak L, Basta P, et al. The influence of supplementation with artichoke (Cynara scolymus L.) extract on selected redox parameters in rowers. Int J Sport Nutr Exerc Metab. 2008.PMID 18562776DOI 10.1123/ijsnem.18.3.313Tier 1, RCT
  22. Hodgin KS, Donovan EK, Kekes-Szabo S, et al. A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Resveratrol (Polygonum cuspidatum), Luteolin, and Fisetin (Rhus succedanea). Int J Environ Res Public Health. 2021.PMID 33802381DOI 10.3390/ijerph18052483Tier 1, RCT
  23. Gelabert-Rebato M, Wiebe JC, Martin-Rincon M, et al. Enhancement of Exercise Performance by 48 Hours, and 15-Day Supplementation with Mangiferin and Luteolin in Men. Nutrients. 2019.PMID 30736383DOI 10.3390/nu11020344Tier 1, RCT
  24. Feltrin C, Farias IV, Sandjo LP, et al. Effects of Standardized Medicinal Plant Extracts on Drug Metabolism Mediated by CYP3A4 and CYP2D6 Enzymes. Chem Res Toxicol. 2020.PMID 32786546DOI 10.1021/acs.chemrestox.0c00182Tier 1
  25. Liang Y, Sun B, Yang M, et al. Evaluation of Luteolin Nanosuspensions on Pharmacokinetics of Atorvastatin: Drug-Drug Interactions Using Rat Models. Int J Nanomedicine. 2025.PMID 40046816DOI 10.2147/IJN.S492141Tier 1
  26. Gotardo AT, Mattos MIDS, Hueza IM, et al. The effect of Cynara scolymus (artichoke) on maternal reproductive outcomes and fetal development in rats. Regul Toxicol Pharmacol. 2019.PMID 30611817DOI 10.1016/j.yrtph.2019.01.004Tier 1
  27. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. Updated August 27, 2026.SourceTier 1
  28. Medicines and Healthcare products Regulatory Agency (MHRA). Herbal medicines granted a traditional herbal registration (THR), list dated 29 October 2026. Updated October 29, 2026.SourceTier 1
  29. Health Canada, Natural and Non-prescription Health Products Directorate. Natural Health Products Ingredients Database monograph: Globe Artichoke - Cynara Cardunculus. Updated January 30, 2026.SourceTier 1
  30. Australian Government, Department of Health, Disability and Ageing (Federal Register of Legislation). Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 (F2026L01382), volumes 1 and 2. Updated October 13, 2026.SourceTier 1
  31. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Cynara cardunculus L. (syn. Cynara scolymus L.), folium (EMA/HMPC/194014/2017). Updated March 27, 2018.SourceTier 1
  32. European Medicines Agency. Cynarae folium - herbal medicinal product. not shown (latest document on the page first published 2025-03-13).SourceTier 1
Reviewed by NootropicsWork Editorial Team, editorial team. Checklist logged . Next review due . Report an error